Scarica l'app Stockscreener
4.47
3.95%
0.17
Dopo l'orario di chiusura:
4.48
0.01
+0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché ACB Giù?
Forum
Previsione
Frazionamento azionario
Aurora Cannabis Inc. Borsa (ACB) Ultime notizie
Aurora Cannabis Inc (ACB) (Q4 2025) Earnings Call Highlights: Re - GuruFocus
Aurora Cannabis Reports Record Revenue and Growth - TipRanks
Aurora Cannabis denies news of acquisition of New Zealand’s Medleaf Therapeutics - StratCann
Aurora Cannabis Refutes MedLeaf Acquisition Rumors - mg Magazine
Aurora Cannabis announces new strategic partnership - Investing.com
Aurora Cannabis (ACB) Denies Acquisition of MedLeaf Therapeutics - GuruFocus
Aurora Cannabis Denies Acquisition Rumors of MedLeaf Therapeutics - TipRanks
Aurora Cannabis denies acquisition of MedLeaf Therapeutics - Investing.com
Aurora Cannabis (ACB) Refutes Acquisition Rumors of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Denies News of Acquisition of MedLeaf Therapeutics - StreetInsider
Aurora Cannabis Denies News Of Acquisition Of MedLeaf Therapeutics - Barchart.com
Cannabis Stock Movers For June 18, 2025 - Benzinga
EXCLUSIVE: Medical Cannabis Is Growing And Profitable, Says Aurora CEO — Investors Are Just Missing The Story - Benzinga
Aurora Cannabis Q4 2025 Earnings Call Transcript - MarketBeat
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade) (ACB) - Seeking Alpha
Aurora Cannabis CEO touts ‘pristine’ balance sheet, but shares tumble - BNN Bloomberg
Aurora Cannabis pays $215 million to acquire MedLeaf Therapeutics - MJBizDaily
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics By Investing.com - Investing.com India
Aurora Cannabis announces strategic acquisition of MedLeaf Therapeutics - Investing.com
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market - Benzinga
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline - MSN
Aurora Cannabis (ACB) Reports Significant Q4 Revenue Growth - GuruFocus
Aurora Cannabis Inc. - Baystreet.ca
Aurora Cannabis (ACB) Shares Tumble After Earnings Report | ACB Stock News - GuruFocus
Aurora Cannabis (ACB) Shares Drop Despite Exceeding Revenue Expe - GuruFocus
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates - Yahoo Finance
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Aurora Cannabis drops despite Q4 beat amid concerns over international growth - MSN
Aurora Cannabis (NASDAQ:ACB) Posts Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Aurora Cannabis Achieves Record Revenue and EBITDA in Fiscal 2025 - TipRanks
Aurora Cannabis (ACB) Eyes First Profitable Year Amid Sector Cha - GuruFocus
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter - Placera.se
Aurora Cannabis Q4 Loss Narrows, Adj.EBITDA Surges; Sees Sequentially Weak Demand In Q1; Stock Drops - Nasdaq
ACB Projects Slight Dip in Q1 Revenue with Positive Cash Flow Ou - GuruFocus
Aurora Cannabis Q4 FY25 slides: positive cash flow achieved amid global expansion - Investing.com
Aurora Cannabis Files Full Year Results and Announces Fiscal 202 - GuruFocus
Aurora Cannabis (ACB) Reports Strong Q4 Adjusted EBITDA Growth | ACB Stock News - GuruFocus
ACB in charts: Q4 revenue from medical cannabis, plant propagation climb, consumer segment down - Seeking Alpha
Aurora Cannabis Files Full Year Results And Announces Fiscal 2025 Fourth Quarter - Barchart.com
Germany Legal Cannabis Market Report 2025-2030: Competitive - GlobeNewswire
Aurora Cannabis (ACB) Prepares for Earnings Announcement - GuruFocus
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday By Investing.com - Investing.com Nigeria
GMS, Korn/Ferry, Aurora Cannabis to report earnings Wednesday - Investing.com
Cannabis Hyperemesis Syndrome Class Action Certified - mg Magazine
Aurora Cannabis Faces Class Action Over Lack of Warnings About Cannabinoid Hyperemesis Syndrome - Cannabis Health News
What To Expect From Aurora Cannabis Inc (TSX:ACB) Q4 2025 Earnings - Yahoo Finance
Aurora Cannabis: Poised For Its First Profitable Year (NASDAQ:ACB) - Seeking Alpha
Earnings week ahead: KR, ACN, ACB, and more (NASDAQ:ACB) - Seeking Alpha
Aurora Cannabis (ACB) Projected to Post Earnings on Wednesday - MarketBeat
Cannabis Stock CGC Rallies 39% in Three Months: Time to Buy or Sell? - The Globe and Mail
Aurora Cannabis Requests to Dismiss Class Action Filed by Investors - TradingView
Aurora Cannabis Inc. stock rises Wednesday, outperforms market - MarketWatch
Trading (ACB) With Integrated Risk Controls - news.stocktradersdaily.com
(ACB) Equity Trading Insights (ACB:CA) - news.stocktradersdaily.com
AURORA CANNABIS CHS CLASS ACTION CERTIFIED - Cantech Letter
Learn to Evaluate (ACB) using the Charts (ACB:CA) - news.stocktradersdaily.com
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22 - The Malaysian Reserve
Aurora Cannabis introduces new medical strains in Australia By Investing.com - Investing.com South Africa
Stocks In Play: Aurora Cannabis Inc. By Baystreet.ca - Investing.com Canada
(ACB) Optimized Trading Opportunities (ACB:CA) - news.stocktradersdaily.com
Stocks In Play: Aurora Cannabis Inc. - Barchart.com
Aurora Cannabis introduces new medical strains in Australia - Investing.com Australia
Aurora Cannabis (ACB) Boosts IndiMed Portfolio with New High-Potency Product | ACB Stock News - GuruFocus
2.01%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):